Assessment of bronchodilator responsiveness to salbutamol or ipratropium using different criteria in treatment-naïve patients with asthma and COPD
Background The criteria for significant bronchodilator responsiveness (BDR) were published in 2005 by the European Respiratory Society/American Thoracic Society, which were revised in 2021, however, data on the agreement between these two recommendations in untreated patients with airflow limitation...
| Main Authors: | Zsófia Lázár, Alpár Horváth, Szilvia Kiss-Dala, Zsolt Abonyi-Tóth, Balázs Csoma, Katalin Kontz, Lilla Tamási, Veronika Müller |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | European Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20018525.2024.2328434 |
Similar Items
-
The value of bronchodilation test in the diagnosis and treatment of children with asthma
by: Yang Que, Huang Huarong
Published: (2022-10-01) -
Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
by: Mona Ibrahim Ahmed, et al.
Published: (2023-10-01) -
Comparative study of the bronchodilator efficacy and adverse effects of salbutamol and hyoscine butylbromide in horses with severe asthma
by: Berta Mozo Vives, et al.
Published: (2024-05-01) -
Chest Pain Relieved with a Bronchodilator or Other Asthma Drugs
by: Hirokazu Taniguchi, et al.
Published: (2009-01-01) -
Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline
by: Jeong HJ, et al.
Published: (2016-11-01)